Association of Plasminogen Activator Inhibitor-1 Gene Polymorphisms and Methylene Tetrahydrofolate Reductase Polymorphisms with Spontaneous Miscarriages

Autor: Silva Zupančić-Šalek, Iva Buterin, Petra Bubalo, Zrinko Šalek, Vesna Ðogić
Rok vydání: 2017
Předmět:
Adult
medicine.medical_specialty
Heterozygote
Genotype
030204 cardiovascular system & hematology
03 medical and health sciences
chemistry.chemical_compound
Young Adult
0302 clinical medicine
Pregnancy
Internal medicine
Statistical significance
Plasminogen Activator Inhibitor 1
medicine
Odds Ratio
Humans
Statistical analysis
Genetic Predisposition to Disease
Gene
Methylenetetrahydrofolate Reductase (NADPH2)
Polymorphism
Genetic

biology
business.industry
Significant difference
Gene polymorphisms · Methylene tetrahydrofolate
Hematology
General Medicine
medicine.disease
030210 environmental & occupational health
Abortion
Spontaneous

Endocrinology
chemistry
Methylenetetrahydrofolate reductase
Plasminogen activator inhibitor-1
Case-Control Studies
biology.protein
Female
business
Plasminogen activator
Zdroj: Acta haematologica. 138(2)
ISSN: 1421-9662
Popis: Aim: The objective of this study was to investigate a possible correlation between the plasminogen activator inhibitor-1 (PAI-1) and methylene tetrahydrofolate reductase (MTHFR) polymorphisms and unexplained spontaneous miscarriages (SM). Materials and Methods: PAI-1 polymorphisms were evaluated in 150 women with pregnancy in their history. One hundred women with a history of SM formed the study group and 50 women with normal pregnancies served as the control group. Also, the combination of PAI-1 and MTHFR polymorphisms were evaluated in 138 women out of a total of 150, which included 92 women with SM in their history compared to 46 women in the control group. For statistical analysis, χ2 test, Phi, and Cramer V tests were used; p < 0.05 was taken as a statistically significant result. Results: Our findings show: (a) the correlation between SM and PAI-1 mutations reaches statistical significance (p = 0.026); (b) there was a statistically significant difference between heterozygous PAI-1 in women with only 1 SM compared to the control group (p = 0.047); (c) the comparison of combinations of both mutations, PAI-1 and MTHFR, with the control group demonstrates statistical significance in favor of women with SM and both mutations (p = 0.022). Conclusion: PAI-1 and MTHFR polymorphisms may play an important role in pregnancy complications because heterozygous PAI-1 mutations and a combination of both PAI-1 and MTHFR mutations might contribute to SM.
Databáze: OpenAIRE